The company plans to direct resources away from a drug developed by subsidiary Recognify Life Sciences and toward Atai’s ...

VINE senior center has received a $10,000 grant from the Mankato Clinic Foundation to support four new programs designed to ...

Recognify's CIAS trial for inidascamine missed its main endpoint but showed positive signals in cognitive domains and had a ...

The trial failed to achieve statistical significance in its goal of improved MCCB neurocognitive composite scores.

Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active ...

Mental illness cost Imtiaz Zafar almost a decade of his academic life. Now it motivates him to help find effective treatments ...

The Penn Highlands Healthcare Parkinson’s Support Group will hold its next meeting on Wednesday, Aug. 13 from 2 to 3:30 p.m. at the Parkside Community Center, located at ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

Loxapine may be effective for the treatment of schizophrenia but does not differ greatly from the older typical antipsychotics (chlorpromazine, trifluperazine, perphenazine) or other atypicals ...

Initial results demonstrate numerical improvement of cognitive and functional measures with inidascamine across both active treatment arms compared to placebo, but did not meet statistical ...